Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125506531 | 12550653 | 1 | I | 20160619 | 20160706 | 20160712 | 20160712 | EXP | FR-FRI-1000086028 | FOREST | 87.28 | YR | F | Y | 0.00000 | 20160712 | OT | IT | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125506531 | 12550653 | 1 | PS | NEBIVOLOL. | NEBIVOLOL | 1 | Oral | 5 MG | Y | 21742 | 5 | MG | TABLET | QD | |||||
125506531 | 12550653 | 2 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 8 MG | Y | 0 | 8 | MG | QD | ||||||
125506531 | 12550653 | 3 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 16 MG | Y | 0 | 8 | MG | BID | ||||||
125506531 | 12550653 | 4 | SS | LOXEN | NICARDIPINE HYDROCHLORIDE | 1 | Oral | 50 MG | Y | 0 | 50 | MG | QD | ||||||
125506531 | 12550653 | 5 | C | GLICLAZIDE | GLICLAZIDE | 1 | 30 MG | 0 | 30 | MG | QD | ||||||||
125506531 | 12550653 | 6 | C | ARIMIDEX | ANASTROZOLE | 1 | 1 MG | 0 | 1 | MG | QD | ||||||||
125506531 | 12550653 | 7 | C | SEROPLEX | ESCITALOPRAM OXALATE | 1 | 5 MG | 0 | 5 | MG | QD | ||||||||
125506531 | 12550653 | 8 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 75 MG | 0 | 75 | MG | QD | ||||||||
125506531 | 12550653 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG | 0 | 20 | MG | QD | ||||||||
125506531 | 12550653 | 10 | C | SPECIAFOLDINE | FOLIC ACID | 1 | 5 MG | 0 | 5 | MG | QD | ||||||||
125506531 | 12550653 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | 17 IU | 0 | 17 | IU | QD | ||||||||
125506531 | 12550653 | 12 | C | NOVORAPID | INSULIN ASPART | 1 | AS REQUIRED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125506531 | 12550653 | 1 | Hypertension |
125506531 | 12550653 | 2 | Hypertension |
125506531 | 12550653 | 4 | Hypertension |
125506531 | 12550653 | 5 | Product used for unknown indication |
125506531 | 12550653 | 6 | Product used for unknown indication |
125506531 | 12550653 | 7 | Product used for unknown indication |
125506531 | 12550653 | 8 | Product used for unknown indication |
125506531 | 12550653 | 9 | Product used for unknown indication |
125506531 | 12550653 | 10 | Product used for unknown indication |
125506531 | 12550653 | 11 | Product used for unknown indication |
125506531 | 12550653 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125506531 | 12550653 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125506531 | 12550653 | Bradycardia | |
125506531 | 12550653 | Drug dispensed to wrong patient | |
125506531 | 12550653 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125506531 | 12550653 | 1 | 20160619 | 20160619 | 0 | |
125506531 | 12550653 | 3 | 20160619 | 20160619 | 0 | |
125506531 | 12550653 | 4 | 20160619 | 20160619 | 0 |